CYTOSITE BIOPHARMA, INC.

Medtech

Granzyme B-targeted PET imaging agent for predicting immunotherapy response in cancer

Grants
$1.8M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
25
2 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors$264,066
Federal grantDepartment of Health and Human Services · Phase II · Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors$759,285
Federal grantDepartment of Health and Human Services · Phase II · Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors$774,682
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2221CHEMTOR, L.P.——
2222XIMIO HEALTH, INC.——
2223Temkin Associates, LLC——
2224CYTOSITE BIOPHARMA, INC.——
2225NEOOLIFE, INC.——
2226QUASISTATICS INC——
2227ACLARIS MEDICAL LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 25
  • Compounds Specific To Granzyme B And Uses Thereofapplication
  • Granzyme B Directed Imaging And Therapygranted
  • Compounds Specific To Granzyme B And Uses Thereofapplication
  • Prodrugs For Compounds Specific To Granzyme B And Uses Thereofapplication
  • Granzyme B Directed Imaging And Therapyapplication
  • Granzyme B Directed Imaging And Therapygranted
  • Granzyme B Directed Imaging And Therapyapplication
  • Prodrugs For Compounds Specific To Granzyme B And Uses Thereofapplication
  • Compounds Specific To Granzyme B And Uses Thereofapplication
  • Theranostic Compounds Targeting Granzyme Bapplication
  • Prodrugs For Compounds Specific To Granzyme B And Uses Thereofapplication
  • Compounds Specific To Granzyme B And Uses Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.